Steep Trendelenburg Positioning in gasless vNOTES Procedures: A Retrospective Study
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Objective This retrospective cohort study evaluated the non-inferiority of reduced Trendelenburg positioning (≤ 20°) compared to conventional steep angles (≥ 30°) in gasless transvaginal natural orifice transluminal endoscopic surgery (vNOTES) for benign gynecologic conditions, focusing on perioperative outcomes. Methods 102 patients undergoing gasless vNOTES were stratified into Low- Angle Group (< 30°, mean 20.1°; n = 52) and Steep-Angle Group (≥ 30°, mean 30.8°; n = 50). Primary outcomes included hemodynamics, airway pressure, and conversion rates; secondary outcomes encompassed operative metrics, anesthetic consumption, and 24-h VAS pain scores.Statistical analyses utilized longitudinal mixed models and t-tests. Results The estimation results showed that there is no statistically significant difference between the Low-Angle Group and the Steep-Angle Group in terms of HR, DBP, SBP and airway pressure at different time point during surgery. Airway pressures maintained strict proportionality to tidal volumes in both groups (12–17 cmH 2 O, p = 0.72).No significant differences were found between groups in conversion rates (4.0% vs. 4.3%, p = 0.319), operative/anesthesia duration, blood loss, complications, or most recovery indicators. Anesthetic consumption and VAS scores for shoulder pain/PONV were also similar at 2h and 24h. The Low-Angle Group had significantly lower 24-h abdominal pain VAS (0.46 ± 0.28 vs. 1.12 ± 0.42, p = 0.014), exceeding MCID thresholds. Conclusion Performing gasless vNOTES with ≤ 20° Trendelenburg achieves outcomes equivalent to ≥ 30°, including surgical exposure and safety, while significantly reducing postoperative abdominal pain. This challenges the need for routine steep positioning, establishing ≤ 20° as a viable patient-centered standard, offering equivalent efficacy with less discomfort. Further validation warranted.